" class="no-js "lang="en-US"> Provepharm Life Solutions - Medtech Alert
Saturday, September 30, 2023
Provepharm Life Solutions | Pharmtech Focus

Provepharm Life Solutions

About Provepharm Life Solutions

Provepharm Life Solutions

Provepharm is an affiliated company of the privately-held Provence Technologies Group, devoted to :

• Develop and market drugs made from pharmaceutical active substances (or API) synthesized and patented by its parent company, and
• Licence and market such API to third parties, for human health applications.

Provepharm’s expertise is stemming from experienced managers coming from the international pharmaceutical & medical device industries and enthusiastic project managers focusing on rewarding results.

The team thinks and acts differently in a streamlined organisation with fast decision-making; skills are geared to manage agile processes involving outsourced operations at CROs and CMOs with world-class recognition.
Provepharm recognized the pharmaceutical industry interest to explore known API in new indications and the need for such compounds at quality levels matching ever-increasing technical and regulatory requirements in a changing global world.

Methylene Blue is the first compound which went through such a complete and innovative revamping, from active substance clean chemical synthesis to pharmaceutical R&D and European regulatory recognition in less than three years.

Related Story

Provepharm Receives FDA Marketing Approval in US for BLUDIGO, Its Indigo Carmine Injection Drug Product

July 13 2022

Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that it […]

Provepharm Life Solutions Obtains FDA Authorization to Produce its Active Ingredients for the United States

November 29 2021

Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, […]

Provepharm Life Solutions Raises €120 Million

September 8 2021

Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, […]